These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 106288)

  • 61. [Role of LAAM, methadone and naltrexone in the care of opiate dependence. Experience in Portugal].
    Patricio LD; Miguel N
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():28-30. PubMed ID: 7880010
    [No Abstract]   [Full Text] [Related]  

  • 62. Actions and addiction liabilities of alpha-acetylmethadols in man. 1952 [proceedings].
    Fraser HF; Isbell H
    NIDA Res Monogr; 1976 Jul; (8):58-2. PubMed ID: 995179
    [No Abstract]   [Full Text] [Related]  

  • 63. Implementing a national study of a new maintenance drug.
    Newmann MC; Klett CJ; Stillman R
    Am J Drug Alcohol Abuse; 1975; 2(3-4):289-300. PubMed ID: 1227292
    [No Abstract]   [Full Text] [Related]  

  • 64. Heroin addict responses to six weeks of detoxification with LAAM.
    Sorensen JL; Hargreaves WA; Weinberg JA
    Drug Alcohol Depend; 1982 Feb; 9(1):79-87. PubMed ID: 7084024
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Chromosomes in patients receiving methadone and methadyl acetate.
    Matsuyama SS; Charuvastra VC; Jarvik LF; Fu TK; Sanders K; Yen FS
    Arch Gen Psychiatry; 1978 Aug; 35(8):989-91. PubMed ID: 678048
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).
    Tennant FS; Rawson RA; Pumphrey E; Seecof R
    J Subst Abuse Treat; 1986; 3(3):195-202. PubMed ID: 3806733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Opioid agonist maintenance for probationers: patient-level predictors of treatment retention, drug use, and crime.
    Gryczynski J; Kinlock TW; Kelly SM; O'Grady KE; Gordon MS; Schwartz RP
    Subst Abus; 2012; 33(1):30-9. PubMed ID: 22263711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A cooperative clinical study of methadyl acetate. II. Friday-only regimen.
    Ling W; Klett JC; Gillis RD
    Arch Gen Psychiatry; 1980 Aug; 37(8):908-11. PubMed ID: 7406654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy.
    Hough G; Washton AM; Resnick RB
    NIDA Res Monogr; 1983 Apr; 43():302-9. PubMed ID: 6410265
    [No Abstract]   [Full Text] [Related]  

  • 70. LAAM--a long-acting methadone.
    Med Lett Drugs Ther; 1978 Apr; 20(8):40. PubMed ID: 634227
    [No Abstract]   [Full Text] [Related]  

  • 71. Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status.
    Anglin MD; Conner BT; Annon J; Longshore D
    Addiction; 2007 Sep; 102(9):1432-42. PubMed ID: 17697277
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma l-alpha-Acetylmethadol (LAAM) after acute and chronic administration.
    Henderson GL; Wilson BK; Lau DH
    Clin Pharmacol Ther; 1977 Jan; 21(1):16-25. PubMed ID: 832446
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictors of retention in methadone programs: a signal detection analysis.
    Villafranca SW; McKellar JD; Trafton JA; Humphreys K
    Drug Alcohol Depend; 2006 Jul; 83(3):218-24. PubMed ID: 16384657
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methadyl acetate versus methadone: the experience of one hospital.
    Panell J; Charuvastra VC; Ouren J
    Med J Aust; 1977 Jul; 2(5):150-2. PubMed ID: 331052
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A clinical, controlled study of l-alpha-acetylmethadol in the treatment of narcotic addiction.
    Marcovici M; O'Brien CP; McLellan AT; Kacian J
    Am J Psychiatry; 1981 Feb; 138(2):234-6. PubMed ID: 7457647
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methadone and 1-methadyl acetate: use in management of narcotic addicts. 1971 [proceedings].
    Jaffe JH; Senay EC
    NIDA Res Monogr; 1976 Jul; (8):74-5. PubMed ID: 792703
    [No Abstract]   [Full Text] [Related]  

  • 77. The behavioral, cognitive and physiologic effects of long-term methadone and methadyl treatment. 1973 [proceedings].
    Irwin S; Blachly PH; Marks J; Carlson E; Loewen J; Reade N
    NIDA Res Monogr; 1976 Jul; (8):66-7. PubMed ID: 792699
    [No Abstract]   [Full Text] [Related]  

  • 78. Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
    Schecter A; Kauders F
    Am J Drug Alcohol Abuse; 1975; 2(3-4):443-9. PubMed ID: 1227302
    [No Abstract]   [Full Text] [Related]  

  • 79. Biological correlates of methadone maintenance pharmacotherapy.
    Kreek MJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():9-14. PubMed ID: 7880038
    [No Abstract]   [Full Text] [Related]  

  • 80. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.